Abstract:Integrative approaches that simultaneously model multi-omics data have gained increasing popularity because they provide holistic system biology views of multiple or all components in a biological system of interest. Canonical correlation analysis (CCA) is a correlation-based integrative method. It was initially designed to extract latent features shared between two assays by finding the linear combinations of features – referred to as canonical vectors (CVs) – within each assay that achieve maximal across-assay correlation. Sparse multiple CCA (SMCCA), a widely-used derivative of CCA, allows more than two assays but can result in non-orthogonal CVs when applied to high-dimensional data. Here, we incorporated a variation of the Gram-Schmidt (GS) algorithm with SMCCA to improve orthogonality among CVs. Applying our SMCCA-GS method to proteomics and methylomics data from the Multi-Ethnic Study of Atherosclerosis (MESA) and Jackson Heart Study (JHS), we identified strong associations between blood cell counts and protein abundance. This finding suggests that adjustment of blood cell composition should be considered in protein-based association studies. Importantly, CVs obtained from two independent cohorts demonstrate transferability across the cohorts. For example, proteomic CVs learned from JHS explain similar amounts of blood cell count phenotypic variance in MESA, explaining 39.0% ~ 50.0% variation in JHS and 38.9% ~ 49.1% in MESA, similar transferability was observed for other omics-CV-trait pairs. This suggests that biologically meaningful and cohort-agnostic variation is captured by CVs. We further developed Sparse Supervised Multiple CCA (SSMCCA) to allow supervised integration analysis for more than two assays. We anticipate that applying our SMCCA-GS and SSMCCA on various cohorts would help identify cohort-agnostic biologically meaningful relationships between multi-omics data and phenotypic traits. Author Summary Comprehensive understanding of human complex traits may benefit from incorporation of molecular features from multiple biological layers such as genome, epigenome, transcriptome, proteome, and metabolome. CCA is a correlation-based method for multi-omics data which reduces the dimension of each omic assay to several orthogonal components – commonly referred to as canonical vectors (CVs). The widely-used SMCCA method allows effective dimension reduction and integration of multi-omics data, but suffers from potentially highly correlated CVs when applied to high-dimensional omics data. Here, we improve the statistical independence among the CVs by adopting a variation of the GS algorithm. We applied our SMCCA-GS method to proteomic and methylomic data from two cohort studies, MESA and JHS. Our results reveal a pronounced effect of blood cell counts on protein abundance, strongly suggesting blood cell composition adjustment in protein-based association studies may be necessary. Finally, we present SSMCCA which allows supervised CCA analysis for the association between one phenotype of interest and more than two assays. We anticipate that SMCCA-GS would help reveal meaningful system-level factors from biological processes involving features from multiple assays; and SSMCCA would further empower interrogation of these factors for phenotypic traits related to health and diseases. ### Competing Interest Statement LMR is a consultant for the TOPMed Administrative Coordinating Center (through WeStat).

Sequential double cross-validation for assessment of added predictive ability in high-dimensional omic applications

On the combination of omics data for prediction of binary outcomes

Gaining Confidence on Molecular Classification Through Consensus Modeling and Validation

Two-step penalised logistic regression for multi-omic data with an application to cardiometabolic syndrome

A novel approach for biomarker selection and the integration of repeated measures experiments from two assays

Uncovering Cross-Cohort Molecular Features with Multi-Omics Integration Analysis

Integrative machine learning approaches for predicting disease risk using multi-omics data from the UK Biobank

Improving insights from metabolomic functional analysis combining multivariate tools

Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data

A dropout-regularized classifier development approach optimized for precision medicine test discovery from omics data

Multi-omic prediction of incident type 2 diabetes

Large-scale benchmark study of survival prediction methods using multi-omics data

Predicting type 2 diabetes via machine learning integration of multiple omics from human pancreatic islets

Dual-stage optimizer for systematic overestimation adjustment applied to multi-objective genetic algorithms for biomarker selection

BioM2: biologically informed multi-stage machine learning for phenotype prediction using omics data

Using Machine Learning to Predict Obesity Based on Genome-Wide and Epigenome-Wide Gene–Gene and Gene–Diet Interactions

A robust kernel machine regression towards biomarker selection in multi-omics datasets of osteoporosis for drug discovery

Interpretable Machine Learning Leverages Proteomics to Improve Cardiovascular Disease Risk Prediction and Biomarker Identification

A comprehensive evaluation framework for benchmarking multi-objective feature selection in omics-based biomarker discovery

Compressive Big Data Analytics: An ensemble meta-algorithm for high-dimensional multisource datasets